乳房脂肪填充进展:脂肪制备方法对患者满意度与并发症的12年回顾性比较分析
该12年回顾性研究比较了过滤、沉淀和CELT三种脂肪制备方法在乳房脂肪填充中的患者满意度与并发症率,共纳入572例手术。结果显示CELT组患者满意度显著更高(p<0.001,平均评分1.70)且并发症率最低(8.0%),过滤组和沉淀组并发症率分别为14.9%和16.4%。
要点
- CELT法制备脂肪在乳房填充中并发症率最低(8.0%),患者满意度最高(p<0.001)。
- 过滤法(14.9%)与沉淀法(16.4%)的并发症率高于CELT法。
- 放疗与非放疗患者亚组分析中结局无显著差异(p≥0.06)。
核心结论
- CELT法制备脂肪用于乳房填充可提高患者满意度并降低并发症发生率。
- 仍需更大规模前瞻性研究验证上述发现。
研究设计与样本
- 回顾性比较分析,纳入2010至2022年接受乳房脂肪填充的患者,平均随访20个月(范围3-173个月)。
- 共纳入572例乳房脂肪填充(男7例,女374例),平均年龄45.34±12.2岁(范围14-79岁)。
- 464例(82.8%)填充干预纳入分析,99例(87例患者)失访或拒绝参与问卷。
主要发现
- 手术部位并发症率:CELT组8.0%,过滤组14.9%,沉淀组16.4%。
- CELT组具体并发症:油囊形成4.8%,血肿1.6%,感染0%,术后伤口愈合障碍1.6%。
- CELT组患者满意度显著更高(p<0.001),平均评分1.70(1表示非常满意)。
- 过滤组满意度平均评分2.31,沉淀组平均评分2.43。
- 放疗与非放疗患者亚组分析中结局无显著差异(p≥0.06)。
临床怎么用
- 在乳房脂肪填充中可优先考虑CELT法制备脂肪以改善满意度并降低并发症。
- 需结合患者个体情况与随访条件选择脂肪制备方法。
局限性
- 回顾性设计,存在失访偏倚(99例填充干预失访或拒绝参与)。
- 需更大规模前瞻性研究验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast lipofilling is a commonly utilized method in plastic surgery for breast reconstruction and augmentation. However, the procedure is often limited by the unpredictable survival of fat grafts, leading to dissatisfied patients and associated risks of complications. To address these challenges, recent innovations in fat processing methods, such as the Cell Enriched Lipotransfer (CELT) technique, have been developed to improve both graft retention and overall clinical outcomes. PURPOSE: This study aims to compare patient satisfaction and complication rates associated with different fat preparation techniques- including filtration, sedimentation, and CELT method-in breast lipofilling procedures. METHODS: All patients who underwent breast lipofilling between 2010 and 2022, were identified. Patients were followed for an average of 20 months (range: 3 -173 months). Data including patient demographics, fat preparation methods, and outcomes were extracted from clinical records. Patient satisfaction was assessed using a modified BreastQ questionnaire, and complications were recorded from postoperative follow-ups. RESULTS: We included 572 breast lipofillings (7 male; 374 female) with a mean age of 45.34 ± 12.2 years (range 14-79). Patient demographics did not differ statistically significantly (p = 0.85). A total of 464 lipofilling interventions (82.8%) were eligible for analysis, as 99 lipofilling interventions (87 patients) were lost to follow-up or refused to participate in the questionnaire. The surgical site complication rate of the study was as follows: CELT (8.0%), filtration (14.9%), and sedimentation (16.4%). Specific complications for CELT included oil cyst formation (4.8%), hematomas (1.6%), no infections (0%), and postoperative wound healing disorders (1.6%). The CELT method resulted in a significantly higher patient satisfaction rate (p < 0.001) with a mean score of 1.70 (where 1 indicates very satisfied) and the lowest complication rate of 8.0%. Satisfaction rates for other techniques were as follows: Filtration (2.31) and Sedimentation (mean score of 2.43). In subgroup analyses, outcomes did not differ significantly between radiated and non-radiated patients in this cohort (p ≥ 0.06). CONCLUSION: The Cell Enriched Lipotransfer (CELT) method has emerged as a highly effective fat preparation technique for breast lipofilling, demonstrating enhanced patient satisfaction and a lower incidence of complications. However, further validation through larger-scale, prospective studies is essential to confirm these findings and establish robust evidence.
引用
- Loucas R, Loucas M, Müller R, et al. Advancements in Breast Lipofilling: A 12-Year Retrospective Comparative Analysis of Patient Satisfaction and Complication Rates across Fat Preparation Methods. Plast Reconstr Surg. 2026. PMID: 42320038. doi:10.1097/PRS.0000000000013135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。